中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共112条，第1-10条 帮助

条数/页： 排序方式：
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19
作者:  Wang, Pingyuan;  Zhu, Wen-Ting;  Wang, Yajing;  Song, Shan-Shan;  Xi, Yong
  |  收藏  |  浏览/下载：58/0  |  提交时间：2023/10/17
Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer 期刊论文  OAI收割
JOURNAL OF ADVANCED RESEARCH, 2023, 卷号: 51, 页码: 121-134
作者:  Cheng, Yanan;  Bu, Dechao;  Zhang, Qiaoling;  Sun, Rebecca;  Lyle, Stephen
  |  收藏  |  浏览/下载：6/0  |  提交时间：2023/12/04
YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 20
作者:  Sun, Yuting;  Yang, Hui;  Yuan, Jiaqi;  Wang, Limin;  Song, Shanshan
  |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17
Rucaparib cocrystal: Improved solubility and bioavailability over camsylate 期刊论文  OAI收割
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 卷号: 631, 页码: 10
作者:  Xia, Mengyuan;  Jiang, Yihua;  Cheng, Yinxiang;  Dai, Wenjuan;  Rong, Xiaoyi
  |  收藏  |  浏览/下载：63/0  |  提交时间：2023/04/10
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance 期刊论文  OAI收割
EMBO MOLECULAR MEDICINE, 2023, 页码: 24
作者:  Wang, Li-Min;  Wang, Pingyuan;  Chen, Xiao-Min;  Yang, Hui;  Song, Shan-Shan
  |  收藏  |  浏览/下载：21/0  |  提交时间：2023/04/10
Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)GHSungetal against lung adenocarcinoma 期刊论文  OAI收割
JOURNAL OF ETHNOPHARMACOLOGY, 2023, 卷号: 317
作者:  Zhang, Xingfang;  Wang, Mengyuan;  Liang, Xinxin;  Wang, Jianv;  Zhang, Ming
  |  收藏  |  浏览/下载：4/0  |  提交时间：2023/12/01
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 240, 页码: 114574
作者:  Kayumov, Muzaffar;  Jia, Li;  Pardaev, Azizbek;  Song, Shan-Shan;  Mirzaakhmedov, Sharafitdin
  |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/21
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
  |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/22
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong
  |  收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23
Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer 期刊论文  OAI收割
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 卷号: 23, 期号: 7, 页码: 21
作者:  Reza, Md Selim;  Harun-Or-Roshid, Md;  Islam, Md Ariful;  Hossen, Md Alim;  Hossain, Md Tofazzal
  |  收藏  |  浏览/下载：17/0  |  提交时间：2022/12/07